Literature DB >> 18048762

Cytokines and beta-cell biology: from concept to clinical translation.

Marc Y Donath1, Joachim Størling, Lukas A Berchtold, Nils Billestrup, Thomas Mandrup-Poulsen.   

Abstract

The tale of cytokines and the beta-cell is a long story, starting with in vitro discovery in 1984, evolving via descriptive and phenomenological studies to detailed mapping of the signalling pathways, gene- and protein expression patterns, molecular and biochemical effector mechanisms to in vivo studies in spontaneously diabetic and transgenic animal models. Only very recently have steps been taken to translate the accumulating compelling preclinical data into clinical trials. The aim of this chapter is to present an overview of early and recent key observations from our own groups as well as other laboratories that serve to illuminate the road from concept to clinical translation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18048762     DOI: 10.1210/er.2007-0033

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  87 in total

Review 1.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

Review 2.  Blocking interleukin-1β in acute and chronic autoinflammatory diseases.

Authors:  C A Dinarello
Journal:  J Intern Med       Date:  2011-01       Impact factor: 8.989

3.  Acute cytokine-mediated downregulation of the zinc transporter ZnT8 alters pancreatic beta-cell function.

Authors:  Malek El Muayed; Liana K Billings; Meera R Raja; Xiaomin Zhang; Paul J Park; Marsha V Newman; Dixon B Kaufman; Thomas V O'Halloran; William L Lowe
Journal:  J Endocrinol       Date:  2010-05-27       Impact factor: 4.286

4.  miR-101a and miR-30b contribute to inflammatory cytokine-mediated β-cell dysfunction.

Authors:  Ying Zheng; Zhen Wang; Yiting Tu; Hongwei Shen; Zhijie Dai; Jian Lin; Zhiguang Zhou
Journal:  Lab Invest       Date:  2015-09-14       Impact factor: 5.662

Review 5.  Blockade of interleukin 1 in type 1 diabetes mellitus.

Authors:  Thomas Mandrup-Poulsen; Linda Pickersgill; Marc Yves Donath
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

6.  Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines.

Authors:  M Lundh; D P Christensen; D N Rasmussen; P Mascagni; C A Dinarello; N Billestrup; L G Grunnet; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2010-09-28       Impact factor: 10.122

Review 7.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

Review 8.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

9.  Altering β-cell number through stable alteration of miR-21 and miR-34a expression.

Authors:  Marie Balslev Backe; Guy Wayne Novotny; Dan Ploug Christensen; Lars Groth Grunnet; Thomas Mandrup-Poulsen
Journal:  Islets       Date:  2014       Impact factor: 2.694

10.  Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes.

Authors:  M N Pham; H Kolb; T Battelino; J Ludvigsson; P Pozzilli; F Zivehe; M Roden; T Mandrup-Poulsen; N C Schloot
Journal:  Diabetologia       Date:  2013-03-15       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.